Healthcare, Pharma, Medical Device etc.
Category
Japan, United states of America, Europe, Rest of World
Geographic Coverage
Video URL
USD15,000,000.00
Sale price (USD)
Not Available
Non-exclusive license price (USD)
Not Available
Exclusive license price (USD)
Not Available
Non-exclusive license royalty rate %
Availability
Patent family
Number of members in the patent family
Assignee(s) / Patent owner(s)
To see the additional information details please login and subscribe to a Premium account.

FUTURISTIC SAFE INJECTION SYSTEM-2020 for COVID-19 Vaccination

Patent Granted While the entire humanity is cursed to fight with horrible global pandemic of COVID-19 and is putting herculean efforts in developing effective vaccine to curb the menace, we can’t ignore the fact that mass vaccination of vast global population essentially requires at least equal or greater number of safe, user-friendly, non-reusable, ergonomic syringes as the number of dosage to effectively prevent reuses of syringes at any cost. The reuse of dirty syringes is one of the most alarming drawback associated with the conventional syringes, which claims millions of lives every year. Besides, the Needle-Stick Injuries (NSI), the aspiration and injection of correct dosage, disposal of huge amount of medical waste thereby generated etc. etc. are also the matter of great concerns, which need to be addressed effectively. Our promising, disruptive and cutting-edge “Packaging-cum-Injection” technology completely replaces the need of packaging medicament in vials, ampoules etc. It provides a safe, rapid, low cost and hassle-free injection system, saves invaluable human-hours involved in normal injection procedure by avoiding several time-consuming steps such as aspiration of the correct dosage of medicament in conventional syringe from container to syringe, setting the correct dose, elimination of air bubble etc. etc.; completely avoids reuse of dirty needles, contamination of medicament during transfer, wastage of costly injectables etc. It cuts approximately 70% of hazardous bio-medical waste generated due to disposable syringes and also saves approximately 60-70% raw material used in the manufacturing of such syringes and drug-containers. Besides, it also saves a significant amount of storage, transport, distribution as well as the burden of care and carriage on health workers as this technology requires merely to carry a couple of re-usable injectors and the pack of intended numbers of pre-filled drug-cartridges for mass vaccination. It is compatible with WHO’s standards and guidelines.

$15,000,000 BUY NOW BROKER APPLY submit an inquiry
photo To see the additional information details please login and subscribe to a Plus or Premium account.